Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
The New Eater App Prioritizes Expert Editorial Insights Over AI
Stephanie Wu, Eater's editor-in-chief, joins Cheddar to talk about the company's new restaurant recommendation app and why it doesn't use AI.
Rising from the Storm: The Future of Real Estate Post-Hurricane Milton
CEO of Century 21 Real Estate, Mike Miedler, joins Cheddar to discuss the future of real estate in states that were affected by Hurricanes Helene & Milton.
Little Spoon Campaigns For Stricter Baby Food Regulations in US
A recent study warns that 60% of baby and toddler food sold in major US retailers does not meet international health standards.
Revolutionizing Retail: How AI Makes Shopping on Google Easier Than Ever
Google Shopping is getting a makeover with the help of artificial intelligence and a new 'for you' page. Watch!
How Much Would YOU Invest in Your Kid's Dorm Room Redesign?
Urbanology Designs' Co-Founder & CEO, Ginger Curtis, joins Cheddar to give expert tips on how to revamp your college kid's dorm room. Watch!
How Gen Z is Viewing the 2024 Presidential Election
Dylan Douglas, host of 'Young American with Dylan Douglas,' joins Cheddar to reveal how Gen Z is feeling about the election and what issues matter most to them.
Is Post-Pandemic Revenge Travel Over?
Priceline CEO, Brett Keller, joins Cheddar to discuss the latest travel trends and how Hurricanes Helene & Milton have affected those flying south. Watch!
How the Nike and Hyperice Boots are Helping A-List Athletes
Hyperice CEO, Jim Heuther, joins Cheddar to discuss the company's latest product collaboration with Nike. Find out how it is helping your favorite athletes.
How Robotaxis Are Going to Change the Transportation Space
Founder, Chairman and Principal Analyst of Constellation Research Inc., Ray Wang, reveals how Tesla's Robotaxi is going to disrupt the transportation industry.
